AUXILIUM PHARMACEUTICALS INC Earnings Per Share, Basic and Diluted
AUXILIUM PHARMACEUTICALS INC reported Earnings Per Share, Basic and Diluted of -$1.12 per share for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-05.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2014-05-05
- AUXILIUM PHARMACEUTICALS INC earnings per share, basic and diluted for the quarter ending 2014-09-30 was -$0.65.
- AUXILIUM PHARMACEUTICALS INC earnings per share, basic and diluted for the quarter ending 2014-06-30 was -$0.73, a 183.92% decline year-over-year.
- AUXILIUM PHARMACEUTICALS INC earnings per share, basic and diluted for the quarter ending 2014-03-31 was -$1.12.
- AUXILIUM PHARMACEUTICALS INC earnings per share, basic and diluted for the quarter ending 2013-09-30 was -$0.58.
- AUXILIUM PHARMACEUTICALS INC earnings per share, basic and diluted for fiscal 2011 was -$0.69.
- AUXILIUM PHARMACEUTICALS INC earnings per share, basic and diluted for fiscal 2010 was -$1.08.
- AUXILIUM PHARMACEUTICALS INC earnings per share, basic and diluted for fiscal 2009 was -$1.22.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2014-09-30 | -$0.65 derived: net income ÷ weighted average shares · filed 2014-10-30 | -$1.37 derived: net income ÷ weighted average shares · filed 2014-10-30 | -$2.49 derived: net income ÷ weighted average shares · filed 2014-10-30 | |
| 2014-06-30 | -$0.73 derived: net income ÷ weighted average shares · filed 2014-08-07 | -$1.85 derived: net income ÷ weighted average shares · filed 2014-08-07 | ||
| 2014-03-31 | -$1.12 10-Q · filed 2014-05-05 | |||
| 2013-09-30 | -$0.58 derived: net income ÷ weighted average shares · filed 2014-10-30 | $0.28 derived: net income ÷ weighted average shares · filed 2014-10-30 | $0.12 derived: net income ÷ weighted average shares · filed 2014-10-30 | |
| 2013-06-30 | $0.87 derived: net income ÷ weighted average shares · filed 2014-08-07 | $0.70 derived: net income ÷ weighted average shares · filed 2014-08-07 | ||
| 2013-03-31 | -$0.17 10-Q · filed 2014-05-05 | |||
| 2012-09-30 | -$0.21 10-Q · filed 2012-11-08 | -$0.09 10-Q · filed 2012-11-08 | ||
| 2012-03-31 | -$0.04 10-Q · filed 2013-04-30 | |||
| 2011-12-31 | -$0.25 10-K · filed 2013-02-26 | -$0.33 derived: net income ÷ weighted average shares · filed 2013-02-26 | -$0.44 derived: net income ÷ weighted average shares · filed 2013-02-26 | -$0.69 10-K · filed 2012-02-29 |
| 2011-09-30 | -$0.08 10-K · filed 2013-02-26 | -$0.19 derived: net income ÷ weighted average shares · filed 2013-02-26 | -$0.44 10-Q · filed 2012-11-08 | |
| 2011-06-30 | -$0.11 10-K · filed 2013-02-26 | -$0.36 10-Q · filed 2011-08-02 | ||
| 2011-03-31 | -$0.25 10-K · filed 2013-02-26 | |||
| 2010-12-31 | -$0.34 10-K · filed 2012-02-29 | -$1.08 10-K · filed 2012-02-29 | ||
| 2010-09-30 | -$0.27 10-K · filed 2012-02-29 | -$0.74 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | -$0.28 10-K · filed 2012-02-29 | -$0.47 10-Q · filed 2011-08-02 | ||
| 2010-03-31 | -$0.18 10-K · filed 2012-02-29 | |||
| 2009-12-31 | -$1.22 10-K · filed 2012-02-29 |